Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Circ Cardiovasc Interv. 2016 Jan;9(1):e002766. doi: 10.1161/CIRCINTERVENTIONS.115.002766

Table 4.

Outcomes at 1-Year (Based on Kaplan-Meier Analysis)

Outcome (%): (a) Baseline SR / Discharge SR (b) Baseline SR / Discharge AF (c) Baseline AF / Discharge AF p-value All Groups p-value a vs. b p-value a vs. c p value b vs. c
Mortality
- All cause 15.8 35.7 29.9 <0.0001 <0.001 <0.001 0.16
- Cardiovascular 9.0 20.6 21.0 <0.0001 <0.001 <0.001 0.91
Rehospitalization 15.6 25.7 26.7 <0.0001 0.01 <0.001 0.84
Stroke/TIA 6.3 10.3 9.0 0.19
Major Bleeding 11.5 16.0 16.6 0.03 0.18 0.15 0.96
Major Vascular Event 5.6 4.4 6.8 0.58
Renal Failure requiring dialysis 2.7 7.3 4.6 0.005 0.002 0.03 0.22
New Pacemaker 6.8 16.3 7.0 0.001 0.0004 0.96 0.002
LVEF 60.0 [55.0,64.3] 60.0 [55.0,65.0] 55.6 [50.0,61.0] 0.055
Change in 6MTWD (mean, in meters) 33.1 8.0 38.3 0.32
On Aspirin 86.6 71.4 72.3 <0.0001 0.002 <0.0001 0.89
On Clopidogrel 32.9 27.3 16.3 <0.0001 0.39 <0.0001 0.055